Etablished in Nîmes (France) since 2002 and regarding its initial panel of innovative products and services, IVAGEN made itself rapidly known to the clinical and veterinary diagnostic marketplaces. Through local and specialized distributors working over the 5 continents, IVAGEN support lot of biologists and clinicians worldwide with state-of-the-art technologies and dedicated services.

IVAGEN announced in 2005, the signature of a worldwide agreement with URRMA R&D, to design and market a serological ELISA kit for the detection of anti-R7V antibodies in HIV infected patients.

At the beginning of 2007, IVAGEN concluded a new round of financing to allow a better focus of the existing proficiencies and support new generation products launching.